Propanc Biopharma PPCB
NASDAQ PPCB
$0.51 -0.02 (-3.96%)
At close: Sep 29, 2026 · 4:00 PM EDT

Propanc Biopharma (PPCB) Capital Expenditures (2011 - 2025)

Updated

Propanc Biopharma (PPCB) recorded Capital Expenditures of $4,933 in FY2026 (year ended Jun 30, 2026).

Analysis

Propanc Biopharma (PPCB) Capital Expenditures (2011 - 2025) Analysis & Trends

Starting with FY2011, Propanc Biopharma's Capital Expenditures history includes 5 fiscal years.

  • The FY2026 figure is the highest annual Capital Expenditures since FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.32 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 322.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -763.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 112.20 Mn
10 Propanc Biopharma 595,565.74 595,565.74 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2,267.00
Sep 30, 2025 2,491.00
Mar 31, 2019 1,212.00
Jun 30, 2016 9,203.00
Dec 31, 2015 -3.00
Sep 30, 2015 679.00
Jun 30, 2015 2,983.00
Mar 31, 2015 918.00
Jun 30, 2011 85.00
Mar 31, 2011 72.00
API Access

Propanc Biopharma Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PPCB&period=max&api_key=YOUR_API_KEY